10 Firms Defy Market Pessimism

1. Neuphoria Therapeutics Inc. (NASDAQ:NEUP)

Neuphoria Therapeutics saw its share prices jump by 25.79 percent on Friday to end at $4.39 apiece as investors resorted to bargain-hunting to take advantage of the company’s cheap valuations, as it nears a 52-week low.

In the news, Neuphoria Therapeutics recently regained compliance with the Nasdaq’s minimum bid price requirement, having flagged for falling below the requirement.

In July 2024, the company received a deficiency letter from Nasdaq due to its American Depositary Shares not meeting the $1 minimum bid price over a 30-day period.

The issue is now resolved and the matter is considered closed—a development significant for Neuphoria Therapeutics as falling below the minimum requirement threatens itself from maintaining a position on the stock exchange.

While we acknowledge the potential of NEUP as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter timeframe. If you are looking for an AI stock that is more promising than NEUP but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.

READ NEXT: 20 Best AI Stocks To Buy Now and Complete List of 59 AI Companies Under $2 Billion in Market Cap

Disclosure: None. This article is originally published at Insider Monkey.